
Kenvue Reports Q1 2026 Results Driven by Organic Growth Across Core Health Segments
Kenvue Inc.Description
What this story covers
Kenvue Inc.’s Q1 2026 earnings report highlights organic sales growth in self-care and skin health. The filing emphasizes operational efficiency and a resilient full-year outlook despite potential macroeconomic and currency challenges.
Story snapshot
CompanyKenvue Inc.
TickerKVUE
VariantStandard detailed
Duration5:22
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001944048-26-000097
Sources1
Full Story Script
Content not available for this story.